NCT02954328

Brief Summary

The concurrent performance of two tasks, i.e., dual tasking (DT), is a common and ubiquitous every day phenomena. For example, people frequently walk while talking on a cellphone or drive while talking to a passenger. Often, the performance of one or more of these simultaneously performed tasks may deteriorate when another task is carried out at the same time, even in healthy young adults. This reduction in performance is referred to as the DT deficit or DT cost and is typically much higher in Idiopathic Fallers (IF) than in age-matched controls. In this population the DT cost impairs the gait pattern, as manifested, for example, in increased gait variability, exacerbating instability and fall risk. In the proposed study, would be evaluated the effects of tDCS on dual tasking performance following tDCS. The researchers expect that stimulation of the Pre Frontal Cortex (PFC) (using tDCS) will increase DT performance and prefrontal activation.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 3, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

April 21, 2017

Status Verified

April 1, 2017

Enrollment Period

1.1 years

First QC Date

October 31, 2016

Last Update Submit

April 20, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Immediate change in gait speed

    Gait speed will be assessed under usual and dual task conditions and while negotiating physical obstacles, using a sensorized 7 meter carpet (PKMAS) and wearable body fixed sensors. These measures will be compared to baseline performance.

    1st measure will be taken at baseline ans 2nd immediate post intervention

Secondary Outcomes (2)

  • fNIRS related frontal lobe activation - changes in tissue oxygenation

    1st measure will be taken at baseline ans 2nd immediate post intervention

  • Changes in cognitive performance - Executive Function composite score

    1st measure will be taken at baseline ans 2nd immediate post intervention

Study Arms (1)

tDCS

EXPERIMENTAL

The active tDCS condition will consist of 4 visit: During each visit, subject will receive a single 20-minute session targeting the prefrontal cortices of either real (1.5 mA) or sham tDCS. Total 4 different targets: 1. Sham 2. motor M1 area 3. motor M1 + Dorsolateral Prefrontal cortex 4. Dorsolateral Prefrontal cortex. The tDCS condition will be randomized and double blinded

Device: tDCS

Interventions

tDCSDEVICE

The active tDCS condition will consist of 20 min of continuous stimulation. This amount of stimulation is safe for healthy young and older adults and has been shown to induce acute beneficial changes in cortical excitability and cognitive functions.

Also known as: Transcranial Direct Current Stimulation
tDCS

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • age 65-85 years,
  • ability to walk for 6 minutes unassisted,
  • adequate vision capabilities, and
  • stable medications for the past month.

You may not qualify if:

  • diagnosis of stroke, Parkinson's disease, peripheral neuropathy or other neurologic disorder,
  • lower-extremity deformity, joint replacement, severe arthritis or other diagnosed musculoskeletal disorder that may influence gait,
  • orthostatic hypotension, recent history of syncope or vertigo,
  • myocardial infarction or surgery within the past 6 months,
  • any unstable medical condition,
  • psychiatric co-morbidity (e.g., major depressive disorder as determined by DSM V criteria),
  • likely dementia (i.e., Mini Mental State Exam score \< 24 or based on DSM V),
  • sedating medications (sedatives, anti-psychotics, hypnotics, anti-depressants,
  • colorblindness (confounder for cognitive assessment), or
  • contraindications to tDCS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hebrew Rehabilitation Center / Harvard Medical School

Roslindale, Massachusetts, 02121, United States

RECRUITING

Laboratory for Gait and Neurodynamics, Tel Aviv Sourasky Medical Center

Tel Aviv, 64239, Israel

RECRUITING

Related Publications (2)

  • Zhou J, Hao Y, Wang Y, Jor'dan A, Pascual-Leone A, Zhang J, Fang J, Manor B. Transcranial direct current stimulation reduces the cost of performing a cognitive task on gait and postural control. Eur J Neurosci. 2014 Apr;39(8):1343-8. doi: 10.1111/ejn.12492. Epub 2014 Jan 20.

  • Schneider N, Dagan M, Katz R, Thumm PC, Brozgol M, Giladi N, Manor B, Mirelman A, Hausdorff JM. Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults. J Neuroeng Rehabil. 2021 Feb 1;18(1):23. doi: 10.1186/s12984-021-00826-2.

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Nir Giladi, Prof.

    Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeffrey M Hausdorff, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research and Development

Study Record Dates

First Submitted

October 31, 2016

First Posted

November 3, 2016

Study Start

November 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

April 21, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations